From October 1, 2022 to December 31, 2022, the company has repurchased 827,300 shares, representing 0.1% for CNY 31.5 million. With this, the company has completed the repurchase of 1,257,300 shares, representing 0.15% for CNY 47.3 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.94 CNY | +0.67% | -2.99% | -38.29% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.29% | 1.84B | |
+27.78% | 659B | |
+27.68% | 557B | |
-4.49% | 359B | |
+16.31% | 322B | |
+8.96% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.84% | 149B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.